We are international
publications TEXT SIZE   
myeloma minute    back

Myeloma Minute
June 14, 2012
June 14, 2012
Share the Minute Facebook Tweet! Clinical Trials Donate to the IMF

Need a Last-Minute Gift for Dad?

This year you can let your dad know you care by making a contribution in his name to the International Myeloma Foundation. Select your e-card option here, and remember to schedule the email for Sunday, June 17th!

Upcoming Events

"Making Sense of Treatment" Webcast
Watch top myeloma experts debate the best treatment for patients in this week’s inaugural International Myeloma Working Group Conference Series.

2012 European Hematology Congress: Media Workshop Webcast
This panel discussion, featuring leading myeloma experts from around the world, will focus on advancements in leading therapies presented at the 2012 Congress of the EHA in Amsterdam. Live streamed at 8 p.m. Amsterdam (CEST); 2 p.m. New York (EDT); 11 a.m. California (PDT)
Fri, June 15, 2012

Register for Free Teleconference: Myeloma Updates 2012
Brian G.M. Durie, MD, summarizes highlights of ASCO/ EHA/ IMWG Summit for patients, family members, caregivers and healthcare professionals.
Thur, June 28, 2012

Myeloma Among 50 Cancers Approved for Coverage by 9/11 Health Fund  

The IMF welcomed a federal ruling Friday that will add 50 types of cancer, including myeloma, to those illnesses covered by the $4.3-billion fund established by Congress after the Sept. 11, 2001 terrorist attacks. “This country owes a debt of gratitude to the heroic first responders who, instead of running away from dangerous ash clouds that enveloped the streets of New York, ran toward them in the hopes that they would be able to help save lives,” said Dr. Brian Durie, co-founder and chairman of the IMF. “This decision ensures health coverage for all affected by this tragedy.” READ MORE

VELCADE as a Sub Q Injection … What You Need to Know
A clinical randomized study done in France showed that the benefits derived from receiving VELCADE intravenously or by subcutaneous injection were the same – but that the VELCADE Sub Q injection resulted in less peripheral neuropathy. Click here to view a short video and FAQs with physicians, nurses and patients discussing VELCADE Sub Q and IV.

Our Advocate of the Month Leads the Charge for Patients on Two Fronts
California Inland Empire support group leader Anthony Sibert draws on his activist background to raise awareness of myeloma in the African-American population. Equally important, he strongly believes, is calling attention to the financial burdens confronting all patients. “So much of what affects myeloma patients in terms of medical care—access to a full range of cancer fighting medicine, low or cost-free health insurance, and quality of care—is decided by what our local, state, and federal legislators do in government,” says Sibert. READ MORE
Caregiver Wife’s Blog: Fueled by Passion and Survival
Why do support groups work? Blogger Kim McLaughlin suspects that writer and raconteur Quentin Crisp was onto something when he said, "Health consists of having the same diseases as one's neighbors." The recipe for success that has guided the “neighbors” of Seattle’s myeloma support group calls for equal parts passion, survival instinct and energy. READ MORE
A Patient’s Blog: Tips for Dealing with Treatment Side Effects, Pt. 2
This week, Pat Killingsworth continues sharing suggestions for coping with side effects. “Don’t you hate when you begin reading an article touting ways to help you resolve any number of medically related issues, only to learn that it was so basic that it was a waste of time reading it?” he asks. “I don’t want that to happen here!” READ MORE

Join Our Mailing List

12650 Riverside Drive, Suite 206 | North Hollywood, CA 91607-3421
Privacy Policy | Unsubscribe 

 related articles